查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年欧洲上游生物加工市场预测 - 区域分析 - 按产品类型、工作流程、使用类型和模式
市场调查报告书
商品编码
1567871

2030 年欧洲上游生物加工市场预测 - 区域分析 - 按产品类型、工作流程、使用类型和模式

Europe Upstream Bioprocessing Market Forecast to 2030 - Regional analysis - by Product Type, Workflow, Usage Type, and Mode
出版日期: | 出版商: The Insight Partners | 英文 124 Pages | 订单完成后即时交付

价格

2022年欧洲上游生物加工市场价值为25.8159亿美元，预计2030年将达到70.6978亿美元；预计2022年至2030年复合年增长率为13.4%。

生物製药製造外包推动欧洲上游生物加工市场

大量合约开发和製造组织（CDMO）和合约製造组织（CMO）正在从事生物加工活动，这引发了这些设施对生物反应器的需求。透过生物製程进行药品製造的策略性外包，使生物製药公司能够利用外部合作伙伴在上游流程中的专业知识和先进能力，促进获得专业技术、流程优化专业知识和可扩展的製造能力。透过与 CDMO 和 CMO 合作，生物製药公司可以有效管理製造需求，适应生产需求的波动，并专注于核心研发活动。此外，外包透过利用外部合作伙伴已建立的基础设施和合规设施来提高成本效率并降低风险。外包生物加工功能使生物製药公司能够专注于促进创新、技术进步和整体上游製程扩展。因此，生物製药製造的外包极大地推动了上游生物加工市场的成长。

欧洲上游生物加工市场概况

欧洲上游生物加工市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。由于政府和私人资金可用于生物製品和药品研究，预计将出现强劲的成长率，从而推动创新技术的推出。该地区拥有各种组织和机构，透过会议和其他活动来监督製药业的实践。欧洲的公司一直致力于在各种活动中展示其产品，以便能够加强其客户群并收集有关该地区其他参与者的开发资讯。因此，研究计画、创新产品和会议等活动有利于欧洲上游生物加工市场。

欧洲上游生物加工市场收入及 2030 年预测（百万美元）

欧洲上游生物加工市场细分

欧洲上游生物加工市场根据产品类型、工作流程、使用类型、模式和国家进行细分。根据产品类型，欧洲上游生物加工市场分为生物反应器/发酵槽、细胞培养、过滤器、袋子和容器等。 2022 年，生物反应器/发酵器服务占据最大的市场份额。

根据工作流程，欧洲上游生物加工市场分为培养基製备、细胞培养和细胞分离。 2022 年，细胞分离占据最大的市场份额。

根据使用类型，欧洲上游生物加工市场分为一次性和多用途。 2022年一次性使用将占据更大的市场份额

根据模式，欧洲上游生物加工市场分为内部和外包。 2022 年，In-house 占据了更大的市场份额。

根据国家/地区，欧洲上游生物加工市场分为英国、德国、法国、义大利、西班牙和欧洲其他地区。 2022年，德国将主导欧洲上游生物加工市场份额。

Thermo Fisher Scientific Inc、Esco Micro Pte Ltd、Cellexus International Ltd、Sartorius AG、Getinge AB、Merck KGaA、Corning Inc 和 Entegris Inc 是欧洲上游生物加工市场的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲上游生物加工市场格局

  • 概述
  • PEST分析

第 5 章：欧洲上游生物加工市场 - 主要市场动态

  • 市场驱动因素
    • 一次性生物反应器的商业用途
    • 生物製药製造外包
    • 医药和生技产业快速成长
  • 市场限制
    • 严格的规范架构
  • 市场机会
    • 技术进步
  • 未来趋势
    • 加大生医产业研发投入
  • 驱动因素和限制的影响：

第 6 章：上游生物加工市场 - 欧洲分析

第 7 章：欧洲上游生物加工市场分析 - 按产品类型

  • 生物反应器/发酵罐
  • 细胞培养
  • 过滤器
  • 袋子和容器
  • 其他的

第 8 章：欧洲上游生物加工市场分析 - 按工作流程

  • 媒体准备
  • 细胞培养
  • 细胞分离

第 9 章：欧洲上游生物加工市场分析 - 按使用类型

  • 一次使用
  • 多用途

第 10 章：欧洲上游生物加工市场分析 - 按模式

  • 内部
  • 外包

第 11 章：欧洲上游生物加工市场 - 国家分析

  • 欧洲市场概况
    • 欧洲
      • 英国
      • 德国
      • 法国
      • 义大利
      • 西班牙
      • 欧洲其他地区

第 12 章：产业格局

  • 概述
  • 上游生物加工市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 13 章：公司简介

  • Thermo Fisher Scientific Inc
  • Esco Micro Pte Ltd
  • Cellexus International Ltd
  • Sartorius AG
  • Getinge AB
  • Merck KGaA
  • Corning Inc
  • Entegris Inc

第 14 章：附录

Product Code: BMIRE00030684

The Europe upstream bioprocessing market was valued at US$ 2,581.59 million in 2022 and is expected to reach US$ 7,069.78 million by 2030; it is estimated to grow at a CAGR of 13.4% from 2022 to 2030.

Outsourcing of Biopharmaceutical Manufacturing Drives Europe Upstream Bioprocessing Market

A large number of contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs) are engaging in bioprocessing activities, which triggers the demand for bioreactors in these facilities. The strategic outsourcing of pharmaceutical manufacturing through bioprocessing allows biopharmaceutical companies to leverage external partners' expertise and advanced capabilities in upstream processes, facilitating access to specialized technologies, process optimization expertise, and scalable manufacturing capacity. By partnering with CDMOs and CMOs, biopharmaceutical firms can efficiently manage manufacturing needs, accommodate fluctuations in production demands, and focus on core research and development activities. Additionally, outsourcing offers cost efficiencies and risk mitigation by leveraging external partners' established infrastructure and regulatory-compliant facilities. Outsourcing the bioprocessing functions allows biopharmaceutical companies to focus on fostering innovation, technological advancements, and overall upstream process expansion. Thus, the outsourcing of biopharmaceutical manufacturing significantly drives the growth of the upstream bioprocessing market.

Europe Upstream Bioprocessing Market Overview

The Europe upstream bioprocessing market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. It is expected to register a robust growth rate owing to the availability of government and private funding for research in biologics and pharmaceuticals, leading to the launch of innovative technologies. The region has various organizations and bodies that monitor the practices being carried out in the pharmaceutical industry through conferences and other events. Companies in Europe have been focusing on showcasing their products at various events to be able to strengthen their customer base and collect information regarding developments made by any other players in the region. Thus, research initiatives, innovative products, and events such as conferences benefit the upstream bioprocessing market in Europe.

Europe Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million)

Europe Upstream Bioprocessing Market Segmentation

The Europe upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country. Based on product type, the Europe upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters services held the largest market share in 2022.

Based on workflow, the Europe upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022.

Based on usage type, the Europe upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022

Based on mode, the Europe upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house held a larger market share in 2022.

Based on country, the Europe upstream bioprocessing market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe upstream bioprocessing market share in 2022.

Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Cellexus International Ltd, Sartorius AG, Getinge AB, Merck KGaA, Corning Inc, and Entegris Inc are some of the leading companies operating in the Europe upstream bioprocessing market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Upstream Bioprocessing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Europe Upstream Bioprocessing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Commercial Use of Single-Use Bioreactors
    • 5.1.2 Outsourcing of Biopharmaceutical Manufacturing
    • 5.1.3 Rapid Growth of Pharmaceutical and Biotechnology Industries
  • 5.2 Market Restraints
    • 5.2.1 Stringent Regulatory Framework
  • 5.3 Market Opportunities
    • 5.3.1 Technological Advancements
  • 5.4 Future Trends
    • 5.4.1 Increasing Investments in R&D in Biopharmaceutical Industry
  • 5.5 Impact of Drivers and Restraints:

6. Upstream Bioprocessing Market - Europe Analysis

7. Europe Upstream Bioprocessing Market Analysis - by Product Type

  • 7.1 Bioreactors/Fermenters
    • 7.1.1 Overview
    • 7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Cell Culture
    • 7.2.1 Overview
    • 7.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Filters
    • 7.3.1 Overview
    • 7.3.2 Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Bags and Containers
    • 7.4.1 Overview
    • 7.4.2 Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Upstream Bioprocessing Market Analysis - by Workflow

  • 8.1 Media Preparation
    • 8.1.1 Overview
    • 8.1.2 Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Cell Culture
    • 8.2.1 Overview
    • 8.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Cell Separation
    • 8.3.1 Overview
    • 8.3.2 Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Upstream Bioprocessing Market Analysis - by Usage Type

  • 9.1 Single-use
    • 9.1.1 Overview
    • 9.1.2 Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Multi-use
    • 9.2.1 Overview
    • 9.2.2 Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Upstream Bioprocessing Market Analysis - by Mode

  • 10.1 In-house
    • 10.1.1 Overview
    • 10.1.2 In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Outsourced
    • 10.2.1 Overview
    • 10.2.2 Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Upstream Bioprocessing Market - Country Analysis

  • 11.1 Europe Market Overview
    • 11.1.1 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.2 UK
      • 11.1.1.3 UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.1 UK: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.3.2 UK: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.3.3 UK: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.3.4 UK: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.4 Germany
      • 11.1.1.5 Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.1 Germany: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.5.2 Germany: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.5.3 Germany: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.5.4 Germany: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.6 France
      • 11.1.1.7 France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.7.1 France: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.7.2 France: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.7.3 France: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.7.4 France: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.8 Italy
      • 11.1.1.9 Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.9.1 Italy: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.9.2 Italy: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.9.3 Italy: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.9.4 Italy: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.10 Spain
      • 11.1.1.11 Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.11.1 Spain: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.11.2 Spain: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.11.3 Spain: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.11.4 Spain: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.12 Rest of Europe
      • 11.1.1.13 Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.13.1 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.13.2 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.13.3 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.13.4 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Mode

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Upstream Bioprocessing Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Thermo Fisher Scientific Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Esco Micro Pte Ltd
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Cellexus International Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Sartorius AG
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Getinge AB
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Merck KGaA
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Corning Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Entegris Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Upstream Bioprocessing Market Segmentation
  • Table 2. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 3. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 4. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 5. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 6. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Country
  • Table 7. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 8. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 9. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 10. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 11. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 12. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 13. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 14. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 15. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 16. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 17. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 18. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 19. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 20. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 21. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 22. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 23. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 24. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 25. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 26. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 27. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 28. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 29. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 30. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 31. Recent Organic Growth Strategies in Upstream Bioprocessing Market
  • Table 32. Recent Inorganic Growth Strategies in the Upstream Bioprocessing Market
  • Table 33. Glossary of Terms, Upstream Bioprocessing Market

List Of Figures

  • Figure 1. Upstream Bioprocessing Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Europe Upstream Bioprocessing Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Upstream Bioprocessing Market Revenue (US$ Million), 2020-2030
  • Figure 6. Upstream Bioprocessing Market Share (%) - by Product Type (2022 and 2030)
  • Figure 7. Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Upstream Bioprocessing Market Share (%) - by Workflow (2022 and 2030)
  • Figure 13. Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Upstream Bioprocessing Market Share (%) - by Usage Type (2022 and 2030)
  • Figure 17. Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Upstream Bioprocessing Market Share (%) - by Mode (2022 and 2030)
  • Figure 20. In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Europe: Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. Europe: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 24. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Growth Strategies in Upstream Bioprocessing Market